Deep dive health check aims to cut COPD Flare-Ups and steroid harm

NCT ID NCT07460154

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests a detailed half-day health assessment for people with COPD who have frequent flare-ups requiring steroid tablets. The assessment checks lung health, other conditions like heart disease, and lifestyle factors, then creates a personalized treatment plan. Researchers will track whether this approach reduces the number of steroid courses needed over the next year. The goal is to improve COPD management and prevent side effects from repeated steroid use.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

What this could lead to
If successful, this approach could reduce COPD flare-ups and the need for steroid tablets, improving patient health and quality of life.
What could go wrong
This is a small, early-stage study without a control group, so results may not apply broadly. The assessment is complex and may not be practical in all clinics.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Northumbria NHS Foundation Trust

    RECRUITING

    North Shields, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.